HDFCCC K12 Physician Scientist Program in Clinical Oncology

Image
Physician Scientist Program in Clinical Oncology

Applications due Jan. 3, 2025, by 8am. RFA hereApply

The goal of the HDFCCC K12 Physician Scholar Program in Clinical Oncology is to foster the development of the next generation of clinical scientists to be effective partners with discovery scientists and conduct high-impact and innovative patient-centered cancer research. The program is housed in the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC) and leverages the exceptional research, clinical, and training environment of one of the world’s leading health sciences institutes. The program integrates the HDFCCC's strengths in basic cancer research, experimental therapeutics, clinical research methodology, and expertise in cancer-related translational research, imaging, patient-reported outcomes, biomarkers, healthcare disparities, community engagement, and biostatistics. 

For more information email Jennifer Seuferer.

 

Upcoming K12 Program Seminars - Register here

From Concept to Completion, Strategies for Successful Clinical Trials

This series of seminars provides high-yield, practical information about designing, funding, and conducting patient-facing oncology trials. Each year 7 seminars are offered. If you attend at least 6 within a 2-year time frame, you can receive the Concept to Completion Certificate of Completion. Open to senior fellows and early career faculty. Contact Jennifer Seuferer for more information. Register here. 

Aug

1. Fostering Diversity in Clinical Research - Aug. 15, 2024, 2pm - 4pm

2. Protocol Structure & review - Aug. 29, 2024, 2pm-4pm

Nov

3. Informed Consent and Clinical Trial Ethics - Nov. 7, 2024, 2pm - 4pm

4. Types of Trials and Sponsors and the General Activation Process - Nov. 14, 2024, 2pm - 4pm

Feb

5. Clinical trial design and data analysis

6. Clinical outcomes research, PROs & database topics

May 7. Building your research portfolio & keeping it in the black

 

Career Development and Leadership Seminar Series

This seminar series includes career development and leadership topics to help physician scientists advance their careers. It's a 2-year curriculum with topics repeating every other year. All the seminars are listed below, however, for any given year, only half of them will take place (the other half will occur the following year).  They are scheduled in blocks (July - December and January - June).  Register here.

July

1. Demystifying the Climb: Promotions at UCSF - Sept. 12, 2024, 2pm - 4pm

2. Promoting an Inclusive Environment 

October

3. Strategic Service Roles and Building Networks - Oct. 24, 2024, 2pm - 4pm

4. Organizational Structure of an NCI Designated Cancer Center 

January

5.  Engaging community in your work- how to do it and why it matters

6. Communication & conflict management especially in multi-disciplinary teams

April

7. Building, leading and sustaining an effective team, including planning for funding

8. Maximizing the impact of your work – preprints, twitter, social media

May 9. Leveraging philanthropy to build and sustain your research program

 

Clinically Driven Discovery Science in Cancer - From Bench to Bedside Workshop

Next workshop will be in July 2025.

Lead by Michelle Arkin, PhD, Michael Cheng, MD, and Trever Bivona, MD/PhD

This workshop will provide training and a rigorous foundation for hypothesis-driven patient-focused research, covering clinical and preclinical iteration. Attendees will participate in interactive didactic and individualized discussions that culminate in a translational and/or clinical research protocol synopsis focused on testing a patient-centered hypothesis of their interest(s).

For most topics, participants will first view online lectures, followed by in-person, small group discussion. Participants must be able to participate in the in-person group discussions to join the course. Open to postdocs, graduate students, senior clinical fellows and early career faculty. 

Learning Objectives:

  • Summarize the stages of preclinical foundations
  • Describe combination studies and when to use them
  • Discuss pharmacodynamic studies and radionuclide therapies
  • Examine drug development from the perspective of a clinical pharmacist
  • Summarize clinical trial design

 

Date

Topic

July 8

Orientation via zoom

Course website & pre-recorded videos open

Monday 7/22

1-1:30pm

Lunch

1:30-2:45pm

Preclinical Foundations & Case Studies (Michelle Arkin, PhD)

2:45-3pm

Class Project Introduction

Tuesday 7/23

3-3:45pm

Combination therapies in Cancer (Cathy Smith, MD)

3:45-4:30pm

Combination Studies (Michael Cheng, MD)

 

Project Work

Wednesday 7/24

TBD

Radionuclide Therapies (Mike Evans, PhD)

4-5pm

Pharmacodynamic Studies (Adil Daud, MD)

 

Class project work

Thursday 7/25

2-3pm

Drug development from the perspective of a clinical pharmacist – (Lisa Janssen Carlson, Pharm D)

3-4pm

Synopsis of Clinical Trial Design Group Discussion (Michael Cheng, MD)

 

Class project work

Friday 7/26

TBD

Project presentations